Helius Medical Announces Study Results Demonstrate 56% Of Study Participants Who Were Previously Unable To Work Due To Traumatic Brain Injury Returned To Their Prior Occupations After 14 Weeks Of PoNS Therapy
Portfolio Pulse from Benzinga Newsdesk
Helius Medical has announced that 56% of study participants who were previously unable to work due to traumatic brain injury returned to their prior occupations after 14 weeks of PoNS Therapy.
November 06, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Helius Medical's PoNS Therapy has shown promising results in a study, potentially boosting the company's reputation and demand for its therapy.
The positive study results for Helius Medical's PoNS Therapy could lead to increased demand for the therapy, potentially driving up the company's stock price in the short term. The news directly pertains to the company and its product, making it highly relevant and important for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100